{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:21:23Z","timestamp":1707524483932},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,7]]},"DOI":"10.7759\/cureus.21998","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T22:58:36Z","timestamp":1644274716000},"source":"Crossref","is-referenced-by-count":1,"title":["COVID-19 Infection and Guillain-Barre Syndrome: A Case Series"],"prefix":"10.7759","author":[{"given":"Kendal","family":"Carpenter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romil","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keerti","family":"Deepika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thoyaja","family":"Koritala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitesh","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram Sanjeev","family":"Alur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramesh","family":"Adhikari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishwas S","family":"Mellekate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14368","article-title":"SARS-CoV-2 and Guillain-Barr\u00e9 syndrome: AIDP variant with a favourable outcome","volume":"27","author":"Lascano AM","year":"2020","unstructured":"Lascano AM, Epiney JB, Coen M, et al.. SARS-CoV-2 and Guillain-Barr\u00e9 syndrome: AIDP variant with a favourable outcome. Eur J Neurol. 2020, 27:1751-1753. 10.1111\/ene.14368","journal-title":"Eur J Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27024","article-title":"COVID-19-associated Guillain-Barr\u00e9 syndrome: the early pandemic experience","volume":"62","author":"Caress JB","year":"2020","unstructured":"Caress JB, Castoro RJ, Simmons Z, Scelsa SN, Lewis RA, Ahlawat A, Narayanaswami P. COVID-19-associated Guillain-Barr\u00e9 syndrome: the early pandemic experience. Muscle Nerve. 2020, 62:485-491. 10.1002\/mus.27024","journal-title":"Muscle Nerve"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10124-x","article-title":"Guillain-Barr\u00e9 syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases","volume":"268","author":"Abu-Rumeileh S","year":"2021","unstructured":"Abu-Rumeileh S, Abdelhak A, Foschi M, Tumani H, Otto M. Guillain-Barr\u00e9 syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases. J Neurol. 2021, 268:1133-1170. 10.1007\/s00415-020-10124-x","journal-title":"J Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118568","article-title":"Involvement of the nervous system in COVID-19: the bell should toll in the brain","volume":"262","author":"Satarker S","year":"2020","unstructured":"Satarker S, Nampoothiri M. Involvement of the nervous system in COVID-19: the bell should toll in the brain. Life Sci. 2020, 262:118568. 10.1016\/j.lfs.2020.118568","journal-title":"Life Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps","volume":"15","author":"Leonhard SE","year":"2019","unstructured":"Leonhard SE, Mandarakas MR, Gondim FA, et al.. Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps. Nat Rev Neurol. 2019, 15:671-683. 10.1038\/s41582-019-0250-9","journal-title":"Nat Rev Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1493415","article-title":"Immunotherapy of Guillain-Barr\u00e9 syndrome","volume":"14","author":"Liu S","year":"2018","unstructured":"Liu S, Dong C, Ubogu EE. Immunotherapy of Guillain-Barr\u00e9 syndrome. Hum Vaccin Immunother. 2018, 14:2568-2579. 10.1080\/21645515.2018.1493415","journal-title":"Hum Vaccin Immunother"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.53854\/liim-2904-1","article-title":"Infection risk with the use of interleukin inhibitors in hospitalized patients with COVID- 19: a narrative review","volume":"4","author":"Koritala T","year":"2021","unstructured":"Koritala T, Pattan V, Tirupathi R, et al.. Infection risk with the use of interleukin inhibitors in hospitalized patients with COVID- 19: a narrative review. Infez Med. 2021, 4:495-503. 10.53854\/liim-2904-1","journal-title":"Infez Med"},{"key":"ref8","article-title":"A fatal case of myasthenia gravis exacerbation in Covid-19 leading to acute respiratory failure","volume":"6","author":"Adhikari R","year":"2020","unstructured":"Adhikari R, Suram VK, Deepika K, Joseph T. A fatal case of myasthenia gravis exacerbation in Covid-19 leading to acute respiratory failure. J Neurol Transl Neurosci. 2020, 6:1087.","journal-title":"J Neurol Transl Neurosci"},{"key":"ref9","article-title":"Guillain-Barr\u00e9 syndrome","volume":"69","author":"Newswanger DL","year":"2004","unstructured":"Newswanger DL, Warren CR. Guillain-Barr\u00e9 syndrome. Am Fam Phys. 2004, 69:2405-2410.","journal-title":"Am Fam Phys"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s1734-1140(10)70261-9","article-title":"Guillain-Barr\u00e9 syndrome (GBS)","volume":"62","author":"Pithadia AB","year":"2010","unstructured":"Pithadia AB, Kakadia N. Guillain-Barr\u00e9 syndrome (GBS). Pharmacol Rep. 2010, 62:220-232. 10.1016\/s1734-1140(10)70261-9","journal-title":"Pharmacol Rep"},{"key":"ref11","article-title":"Guillain-Barr\u00e9 syndrome","volume":"87","author":"Walling AD","year":"2013","unstructured":"Walling AD, Dickson G. Guillain-Barr\u00e9 syndrome. Am Fam Phys. 2013, 87:191-197.","journal-title":"Am Fam Phys"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-324837","article-title":"Guillain-Barr\u00e9 syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions","volume":"92","author":"Filosto M","year":"2021","unstructured":"Filosto M, Cotti Piccinelli S, Gazzina S, et al.. Guillain-Barr\u00e9 syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions. J Neurol Neurosurg Psychiatry. 2021, 92:751-756. 10.1136\/jnnp-2020-324837","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2021.100203","article-title":"GM1 ganglioside antibody and COVID-19 related Guillain Barre Syndrome - a case report, systemic review and implication for vaccine development","volume":"12","author":"Dufour C","year":"2021","unstructured":"Dufour C, Co TK, Liu A. GM1 ganglioside antibody and COVID-19 related Guillain Barre Syndrome - a case report, systemic review and implication for vaccine development. Brain Behav Immun Health. 2021, 12:100203. 10.1016\/j.bbih.2021.100203","journal-title":"Brain Behav Immun Health"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa433","article-title":"Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barr\u00e9 syndrome","volume":"144","author":"Keddie S","year":"2021","unstructured":"Keddie S, Pakpoor J, Mousele C, et al.. Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barr\u00e9 syndrome. Brain. 2021, 144:682-693. 10.1093\/brain\/awaa433","journal-title":"Brain"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.2139\/ssrn.3993979","article-title":"SARS-CoV-2 omicron variant exponential","author":"Holmes Jr L","year":"2021","unstructured":"Holmes Jr L, Dabney K, Ogundele B, et al.. SARS-CoV-2 omicron variant exponential. SSRN. 2021,","journal-title":"SSRN"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.npbr.2020.05.008","article-title":"Neurological manifestations of COVID-19 and other coronaviruses: a systematic review","volume":"37","author":"Correia AO","year":"2020","unstructured":"Correia AO, Feitosa PW, Moreira JL, Nogueira S\u00c1R, Fonseca RB, Nobre ME. Neurological manifestations of COVID-19 and other coronaviruses: a systematic review. Neurol Psychiatry Brain Res. 2020, 37:27-32. 10.1016\/j.npbr.2020.05.008","journal-title":"Neurol Psychiatry Brain Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/85973-covid-19-infection-and-guillain-barre-syndrome-a-case-series","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:44:39Z","timestamp":1707507879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/85973-covid-19-infection-and-guillain-barre-syndrome-a-case-series"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,7]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.21998","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,7]]}}}